Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Tibet Cheezheng Tibetan Medicine Co., Ltd.

Why is Tibet Cheezheng Tibetan Medicine Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 10.82% and Operating profit at 10.36% over the last 5 years

Negative results in Dec 25

DIVIDEND PAYOUT RATIO(Y) Lowest at 0%
ROCE(HY) Lowest at 14.34%
RAW MATERIAL COST(Y) Grown by 101.24% (YoY)

Underperformed the market in the last 1 year

The stock has generated a return of 0.14% in the last 1 year, much lower than market (China Shanghai Composite) returns of 13.33%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Tibet Cheezheng Tibetan Medicine Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Tibet Cheezheng Tibetan Medicine Co., Ltd.

0.14%

0.16

37.13%

China Shanghai Composite

13.33%

0.90

14.74%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

10.82%

EBIT Growth (5y)

10.36%

EBIT to Interest (avg)

9.32

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.34

Sales to Capital Employed (avg)

0.39

Tax Ratio

10.20%

Dividend Payout Ratio

34.61%

Pledged Shares

Institutional Holding

ROCE (avg)

16.58%

ROE (avg)

15.58%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.69

EV to EBIT

22.04

EV to EBITDA

17.77

EV to Capital Employed

5.29

EV to Sales

5.44

PEG Ratio

Dividend Yield

2.91%

ROCE (Latest)

23.99%

ROE (Latest)

13.09%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

NET PROFIT(9M)

Higher at CNY 528.48 MM

NET SALES(Q)

Highest at CNY 893.07 MM

PRE-TAX PROFIT(Q)

At CNY 261.92 MM has Grown at 54.19%

-11What is not working for the Company

DIVIDEND PAYOUT RATIO(Y)

Lowest at 0%

ROCE(HY)

Lowest at 14.34%

RAW MATERIAL COST(Y)

Grown by 101.24% (YoY

CASH AND EQV(HY)

Lowest at CNY 3,022.12 MM

DEBT-EQUITY RATIO (HY)

Highest at 0 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 0 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 0 times

DIVIDEND PER SHARE(HY)

Lowest at CNY 0

EPS(Q)

Lowest at CNY 0

Here's what is working for Tibet Cheezheng Tibetan Medicine Co., Ltd.

Net Sales

Highest at CNY 893.07 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

At CNY 261.92 MM has Grown at 54.19%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Higher at CNY 528.48 MM

than preceding 12 month period ended Dec 2025

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

Net Profit (CNY MM)

Here's what is not working for Tibet Cheezheng Tibetan Medicine Co., Ltd.

Dividend Payout Ratio

Lowest at 0% and Fallen

In each year in the last five years

MOJO Watch

Company is distributing lower proportion of profits generated as dividend

DPR (%)

EPS

Lowest at CNY 0

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)

Cash and Eqv

Lowest at CNY 3,022.12 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at 0 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 0 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 0 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Dividend per share

Lowest at CNY 0

in the last five years

MOJO Watch

Company is distributing lower dividend than previous years

DPS (CNY)

Raw Material Cost

Grown by 101.24% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales